Cargando…

The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus

BACKGROUND/AIMS: Coenzyme Q(10) (CoQ(10)) has antioxidant effects and is commercially available and marketed extensively. However, due to its low bioavailability, its effects are still controversial. We developed a water-soluble CoQ(10)-based micelle formulation (CoQ(10)-W) and tested it in an exper...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Yi, Luo, Kang, Cui, Sheng, Lim, Sun Woo, Shin, Yoo Jin, Ko, Eun Jeong, Kim, Ju Hwan, Chung, Sang J., Bae, Soo Kyung, Chung, Byung Ha, Yang, Chul Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652663/
https://www.ncbi.nlm.nih.gov/pubmed/32279476
http://dx.doi.org/10.3904/kjim.2019.269
_version_ 1783607737330958336
author Quan, Yi
Luo, Kang
Cui, Sheng
Lim, Sun Woo
Shin, Yoo Jin
Ko, Eun Jeong
Kim, Ju Hwan
Chung, Sang J.
Bae, Soo Kyung
Chung, Byung Ha
Yang, Chul Woo
author_facet Quan, Yi
Luo, Kang
Cui, Sheng
Lim, Sun Woo
Shin, Yoo Jin
Ko, Eun Jeong
Kim, Ju Hwan
Chung, Sang J.
Bae, Soo Kyung
Chung, Byung Ha
Yang, Chul Woo
author_sort Quan, Yi
collection PubMed
description BACKGROUND/AIMS: Coenzyme Q(10) (CoQ(10)) has antioxidant effects and is commercially available and marketed extensively. However, due to its low bioavailability, its effects are still controversial. We developed a water-soluble CoQ(10)-based micelle formulation (CoQ(10)-W) and tested it in an experimental model of tacrolimus (TAC)-induced diabetes mellitus (DM). METHODS: We developed CoQ(10)-W from a glycyrrhizic-carnitine mixed layer CoQ(10) micelle preparation based on acyltransferases. TAC-induced DM rats were treated with either lipid-soluble CoQ(10) (CoQ(10)-L) or CoQ(10)-W for 4 weeks. Their plasma and pancreatic CoQ(10) concentrations were measured using liquid chromatography- tandem mass spectrometry. The therapeutic efficacies of CoQ(10)-W and CoQ(10)-L on TAC-induced DM were compared using functional and morphological parameters and their effects on cell viability and reactive oxygen species (ROS) production were also evaluated in cultured rat insulinoma cells. RESULTS: The plasma CoQ(10) level was significantly increased in the CoQ(10)-W group compared to that in the CoQ(10)-L group. Intraperitoneal glucose tolerance tests and glucose-stimulated insulin secretion revealed that CoQ(10)-W controlled hyperglycemia and restored insulin secretion significantly better than CoQ(10)-L. The TAC-mediated decrease in pancreatic islet size was significantly attenuated by CoQ(10)-W but not by CoQ(10)-L. TAC-induced oxidative stress and apoptosis were significantly more reduced by CoQ(10)-W than CoQ(10)-L. Electron microscopy revealed that CoQ(10)-W restored TAC-induced attenuation in the number of insulin granules and the average mitochondrial area, unlike CoQ(10)-L. In vitro studies showed that CoQ(10)-L and CoQ(10)-W both improved cell viability and reduced ROS production in TAC-treated islet cells to a similar extent. CONCLUSIONS: CoQ(10)-W has better therapeutic efficacy than CoQ(10)-L in TAC-induced DM.
format Online
Article
Text
id pubmed-7652663
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Association of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-76526632020-11-18 The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus Quan, Yi Luo, Kang Cui, Sheng Lim, Sun Woo Shin, Yoo Jin Ko, Eun Jeong Kim, Ju Hwan Chung, Sang J. Bae, Soo Kyung Chung, Byung Ha Yang, Chul Woo Korean J Intern Med Original Article BACKGROUND/AIMS: Coenzyme Q(10) (CoQ(10)) has antioxidant effects and is commercially available and marketed extensively. However, due to its low bioavailability, its effects are still controversial. We developed a water-soluble CoQ(10)-based micelle formulation (CoQ(10)-W) and tested it in an experimental model of tacrolimus (TAC)-induced diabetes mellitus (DM). METHODS: We developed CoQ(10)-W from a glycyrrhizic-carnitine mixed layer CoQ(10) micelle preparation based on acyltransferases. TAC-induced DM rats were treated with either lipid-soluble CoQ(10) (CoQ(10)-L) or CoQ(10)-W for 4 weeks. Their plasma and pancreatic CoQ(10) concentrations were measured using liquid chromatography- tandem mass spectrometry. The therapeutic efficacies of CoQ(10)-W and CoQ(10)-L on TAC-induced DM were compared using functional and morphological parameters and their effects on cell viability and reactive oxygen species (ROS) production were also evaluated in cultured rat insulinoma cells. RESULTS: The plasma CoQ(10) level was significantly increased in the CoQ(10)-W group compared to that in the CoQ(10)-L group. Intraperitoneal glucose tolerance tests and glucose-stimulated insulin secretion revealed that CoQ(10)-W controlled hyperglycemia and restored insulin secretion significantly better than CoQ(10)-L. The TAC-mediated decrease in pancreatic islet size was significantly attenuated by CoQ(10)-W but not by CoQ(10)-L. TAC-induced oxidative stress and apoptosis were significantly more reduced by CoQ(10)-W than CoQ(10)-L. Electron microscopy revealed that CoQ(10)-W restored TAC-induced attenuation in the number of insulin granules and the average mitochondrial area, unlike CoQ(10)-L. In vitro studies showed that CoQ(10)-L and CoQ(10)-W both improved cell viability and reduced ROS production in TAC-treated islet cells to a similar extent. CONCLUSIONS: CoQ(10)-W has better therapeutic efficacy than CoQ(10)-L in TAC-induced DM. The Korean Association of Internal Medicine 2020-11 2020-04-14 /pmc/articles/PMC7652663/ /pubmed/32279476 http://dx.doi.org/10.3904/kjim.2019.269 Text en Copyright © 2020 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Quan, Yi
Luo, Kang
Cui, Sheng
Lim, Sun Woo
Shin, Yoo Jin
Ko, Eun Jeong
Kim, Ju Hwan
Chung, Sang J.
Bae, Soo Kyung
Chung, Byung Ha
Yang, Chul Woo
The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus
title The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus
title_full The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus
title_fullStr The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus
title_full_unstemmed The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus
title_short The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus
title_sort therapeutic efficacy of water-soluble coenzyme q10 in an experimental model of tacrolimus-induced diabetes mellitus
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652663/
https://www.ncbi.nlm.nih.gov/pubmed/32279476
http://dx.doi.org/10.3904/kjim.2019.269
work_keys_str_mv AT quanyi thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT luokang thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT cuisheng thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT limsunwoo thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT shinyoojin thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT koeunjeong thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT kimjuhwan thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT chungsangj thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT baesookyung thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT chungbyungha thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT yangchulwoo thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT quanyi therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT luokang therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT cuisheng therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT limsunwoo therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT shinyoojin therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT koeunjeong therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT kimjuhwan therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT chungsangj therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT baesookyung therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT chungbyungha therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus
AT yangchulwoo therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus